All three major indexes have started the year off on the right foot. After touching bear territory last year, they're now posting gains for 2023 so far. Will the next step be a bull market? It's possible -- but it's too early to say whether the market is truly ready to fully recover and thrive.
The Abbott Pandemic Defense Coalition is working nonstop at the front lines of virus surveillance and prevention to help stop outbreaks before they become pandemics.
Abbott Laboratories (NYSE: ABT) has generally been a good investment to hold over the years. Is Abbott a bad-news buy that could turn things around in 2023, or has this once-safe healthcare stock become too risky of an investment to be holding right now? Last month, Abbott reported its fourth-quarter and year-end results for 2022.